A worksite prevention program for construction workers: design of a randomized controlled trial

Hengel, Karen M. Oude; Joling, Catelijne I.; Proper, Karin I.; Blatter, Birgitte M.; Bongers, Paulien M.
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p336
Academic Journal
Background: A worksite prevention program was developed to promote the work ability of construction workers and thereby prolong a healthy working life. The objective of this paper is to present the design of a randomized controlled trial evaluating the effectiveness of that intervention program compared with usual care for construction workers. Methods: The study is designed as a randomized controlled trial with a follow-up of one year. Employees eligible for this study are construction workers performing actual construction work. The worksite intervention will be compared with usual care. This intervention was developed by using the Intervention Mapping approach and consists of the following components: (1) two individual training sessions of a physical therapist to lower the physical workload, (2) a Rest-Break tool to improve the balance between work and recovery, and (3) two empowerment training sessions to increase the influence of the construction workers at the worksite. Outcome measures are assessed at baseline, 3, 6, and 12 months. The primary outcome measures of this study are work ability and health-related quality of life. Secondary outcome measures include need for recovery, musculoskeletal complaints, work engagement and self efficacy. Cost-effectiveness will be evaluated from the company perspective. Moreover, a process evaluation will be conducted. Discussion: The feasibility of the intervention and the study has been enhanced by creating an intervention program that explicitly appeals to construction workers and will not interfere too much with the ongoing construction. The feasibility and effectiveness of this worksite prevention program will be investigated by means of an effect- and a process evaluation. If proven effective, this worksite prevention program can be implemented on a larger scale within the construction industry. Trial Registration: NTR1278


Related Articles

  • Enhancing a sustainable healthy working life: design of a clustered randomized controlled trial. Koolhaas, Wendy; Brouwer, Sandra; Groothoff, Johan W.; van der Klink, Jac J. L. // BMC Public Health;2010, Vol. 10 Issue 1, p461 

    Background: To improve a sustainable healthy working life, we have developed the intervention 'Staying healthy at work', which endeavours to enhance work participation of employees aged 45 years and older by increasing their problem-solving capacity and stimulating their awareness of their role...

  • Factors associated with the ability and willingness to continue working until the age of 65 in construction workers. Oude Hengel, Karen; Blatter, Birgitte; Geuskens, Goedele; Koppes, Lando; Bongers, Paulien // International Archives of Occupational & Environmental Health;Oct2012, Vol. 85 Issue 7, p783 

    Objectives: The working population is aging and a shortage of workers is expected in the construction industry. As a consequence, it is considered necessary that construction workers extend their working life. The purpose of this study was to explore factors associated with construction workers'...

  • Effectiveness of a problem-solving based intervention to prolong the working life of ageing workers. Koolhaas, Wendy; Groothoff, Johan W.; de Boer, Michiel R.; van der Klink, Jac J. L.; Brouwer, Sandra // BMC Public Health;2015, Vol. 15 Issue 1, p1 

    Background: An ageing workforce combined with increasing health problems in ageing workers implies the importance of evidence-based interventions to enhance sustainable employability. The aim of this study is to evaluate the effectiveness of the 'Staying healthy at work' problem-solving based...

  • Key feasibility considerations when conducting vaccine clinical trials in Asia-Pacific countries. Lansang, Elvira Zenaida; Kenneth, Tan; Nayak, Saumya; Lee, Ken J.; Karen, Wai // Vaccine: Development & Therapy;2013, Vol. 3, p1 

    Introduction: Conducting clinical trial feasibility is an important first step in initiating a clinical trial. A robust feasibility process ensures that a realistic capability assessment is made before conducting a trial. A retrospective analysis of vaccine clinical trials was performed to...

  • Getting quick answers to important issues.  // Clinical Trials Administrator;Dec2009, Vol. 7 Issue 12, p136 

    The article recommends the use of feasibility questionnaires for sponsors of clinical trial or clinical research organizations in order to have the appropriate patient population and the resources necessary for a specific clinical trials. It outlines some feasibility questions asking for...

  • Predicting Program Start-Up Using the Stages of Implementation Measure. Saldana, Lisa; Chamberlain, Patricia; Wang, Wei; Hendricks Brown, C. // Administration & Policy in Mental Health & Mental Health Service;Nov2012, Vol. 39 Issue 6, p419 

    Recent efforts to better understand the process of implementation have been hampered by a lack of tools available to define and measure implementation progress. The Stages of Implementation Completion (SIC) was developed as part of an implementation trial of MTFC in 53 sites, and identifies the...

  • Acupuncture for Nonpalliative Radiation Therapy-Related Fatigue: Feasibility Study. Mao, Jun James; Styles, Terry; Cheville, Andrea; Wolf, James; Fernandes, Shawn; Farrar, John T. // Journal of the Society for Integrative Oncology;Spring2009, Vol. 7 Issue 2, p52 

    The purpose of this study was to determine the feasibility of an acupuncture clinical trial to prevent radiation therapy (RT)-induced fatigue. We conducted a cross-sectional survey study and a single-arm acupuncture clinical trial among patients undergoing RT. Patients with a Karnofsky score of...

  • Cohera receives approval for TissuGlu trials.  // Medical Device Daily;10/26/2009, Vol. 13 Issue 206, p7 

    The article reports on the approval received by Cohera Medical in October 2009 for the start of human clinical trials of TissuGlu in Germany. The feasibility study, to be conducted in Bonn, Frankfurt and Freiburg in Germany, will determine whether TissuGlu is effective and safe on wound drainage...

  • Improving site-sponsor-CRO relationship.  // Clinical Trials Administrator;Nov2009, Vol. 7 Issue 11, p127 

    This article offers some tips on improving relations between clinical trial (CT) sites, sponsors, and clinical research organizations (CROs). It advises sponsors to solicit input from CT researchers to resolve problems involving protocols. It also recommends the initiation of feasibility...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics